The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process
The Effects of Carnitine Supplementation on Oocyte Yield and Quality in Women Undergoing IVF
The Obstetrics and Gynaecology Clinic Narodni Front
70 participants
May 15, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions it aims to answer are: * Does supplementation improve the number and quality of oocytes retrieved during IVF treatment? * Does supplementation improve the number and quality of embryos obtained after fertilization? * Does supplementation increase the rates of biochemical and clinical pregnancy? Researchers will compare women receiving supplementation with women not receiving supplementation to determine whether the supplements improve IVF outcomes.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A supplementation group will receive L-carnitine (500 mg) daily for 12 weeks before oocyte retrieval.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07783399